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A 17-year-old boy was admitted with chronic kidney disease
(CKD), polyuria, and polycytemia. Prenatal ultrasound (US)
history included enlarged hyperechogenic kidneys and
polyhydramnios. Since birth, he suffered from polyuria and
polydipsia. At the age of 3 years, renal function was normal;
US showed normal-sized cystic kidneys. Genetic testing for
nephronophthisis excluded NPHP1 gene deletions. At the age
of 15 years, he developed hypertension and polycythemia
requiring phlebotomies; serum creatinine was 1.5 mg/dl; US
revealed normal-sized cystic kidneys. UMOD gene muta-
tions were not found. At admission, serum creatinine was
1.5 mg/dl; creatinine clearance 67 ml/min; plasma sodium
and potassium 142 and 4.5 mEq/l, respectively; uric acid
5.1 mg/dl. Urinalysis was negative; daily urine volume 4 liters;
urinary osmolality 330 mOsmol/kg. Magnetic resonance
imaging revealed normal-sized kidneys and numerous
bilateral cysts (Figure 1). No alteration in glucose metabolism
was found. Water restriction and desmopressin administra-
tion showed a submaximal rise in urine osmolality (481 and
497 mOsm/kg, respectively), suggesting partial nephro-
genic diabetes insipidus (NDI). Sequencing of AVPR2 and
AQP2 genes did not reveal mutations. Hemoglobin was
18 g/dl. Serum erythropoietin concentrations were elevated
(21 mU/ml; n.v. o16 mU/ml). The red blood cell mass was
increased (46 ml/kg). Family investigation revealed a 45-year-
old mother with diabetes mellitus (glycated hemoglobin 7%),
CKD, negative urinalysis, bilateral renal cysts, septate uterus;
a 40-year-old maternal aunt with gestational diabetes, CKD,
negative urinalysis, renal cysts; and a maternal grandfather
affected by CKD and diabetes mellitus (Figure 2). There was
no evidence for NDI or polycythemia in these family
members.
What is your diagnosis?
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Figure 1 | Magnetic resonance images of the index case
showing bilateral renal cysts.
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The Diagnosis | HNF1B nephropathy
The history of the renal disease begins with fetal hyperecho-
genic kidneys with polyhydramnios; after birth, the course of
the renal disease was characterized by polyuria, increase of
cysts, and slowly progression of CKD. The renal phenotype,
the autosomal dominant inheritance of the cystic renal
disease, and the cosegregation of extrarenal manifestation
such as diabetes mellitus and genital malformation are very
reminiscent of HNF1B nephropathy, a dominant disorder
due to mutations in the HNF1B gene.1 The presence of
cosegregating extrarenal phenotype ruled out the first
hypothesis of medullary cystic kidney disease. The absence
of retinitis pigmentosa, hearing loss and mental retardation,
and the mode of inheritance, made also unlikely a diagnosis
of a pleiotropic and recessive ciliopathy, including Bardet-
Biedl or Alström syndrome.
HNF1B gene mutations are among the most important
causes of fetal hyperechogenic kidneys;2 are frequently res-
ponsible for cystic renal dysplasia and renal malformation
of variable severity; and are associated with extrarenal
symptoms, including a monogenic form of diabetes
(MODY-5) and genital malformations.1
Molecular analysis of the HNF1B gene revealed, in the
index case and in the affected mother and aunt, a novel point
mutation in exon 2 (c.436 A4G, N146D). The unaffected
family members did not carry the mutation (Figure 2). The
analysis of the possible impact of amino-acid substitution
N146D on the structure and function of the protein with
bioinformatics tools, PolyPhen-2 and SIFT, predicted,
respectively, a probably damaging mutation (score: 0.999)
and mutation affecting protein structure (score: 0.00). The
mutation was not found in 100 controls and it is not reported
in Exome Variant Server (web-based data server that collect
next-generation exome sequencing data obtained from
samples drawn from large cohort and population-based
studies), further suggesting its pathogenic role.
An intriguing finding in the index case was the presence of
NDI that has never been described in HNF1B mutation
carriers. We can speculate that NDI, with a probable onset in
the prenatal period, might be secondary to the cystic
dysplastic kidneys; alternatively, it might be related to the
transcriptional regulation of HNF1B on the expression of
AVPR2 and AQP2 genes.3 A final point deserving considera-
tion was polycythemia. A disorder with high oxygen affinity
hemoglobin was ruled out; we also excluded the presence of
mutations in JAK2 gene; in the Erythropoietin Receptor gene;
and in the VHL, PHD2, HIF-2 alpha genes (hypoxia-sensing
pathways). We can hypothesize a secondary form of poly-
cythemia with inappropriately high serum erythropoietin
produced by renal cysts, in the context of HNF1B
nephropathy.
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Figure 2 | Pedigree of the family with HNF1B
nephropathy. Arrow indicates the index case. Males and
females are indicated by squares and circles,
respectively; blackened circles and squares represent
affected individuals. Genotype for HNF1B gene mutation
(N146D) is represented for each family member tested.
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